Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  • Tim Pickles
  • Rieke Alten
  • Maarten Boers
  • Vivian Bykerk
  • Jared Christensen
  • Robin Christensen
  • Hubert van Hoogstraten
  • Lee S Simon
  • Lai-Shan Tam
  • Ernest H Choy
Vis graf over relationer

OBJECTIVE: Adaptive trial design was developed initially for oncology to improve trial efficiency. If optimized for rheumatology, it may improve trial efficiency by reducing sample size and time.

METHODS: A systematic review assessed design of phase II clinical trials in rheumatoid arthritis.

RESULTS: Fifty-six trials were reviewed. Most trials had 4 groups (1 control and 3 intervention), with an average group size of 34 patients. American College of Rheumatology 20 measured at 16 weeks was the most commonly used primary endpoint.

CONCLUSION: The next step is to undertake a systematic review of adaptive designs used in early-phase trials in nonrheumatic conditions.

TidsskriftJournal of Rheumatology
Udgave nummer10
Sider (fra-til)1406-1408
Antal sider3
StatusUdgivet - okt. 2019

ID: 58098123